Capital Roundtable

Marquee Sponsors


Association Partners

Data Partners

Marketing Partners


Partial List of
Past Attendees at Similar Conferences

AgCap Partners


Albourne Partners

AMERRA Capital

Andina Family Offices

Andromeda Group

Angelo Gordon & Co.

Arlon Group

Armory Securities

Bell Farms


Biomega AS

BJC HealthCare

Blue Road Capital

Cambridge Assoc.

Coda Capital Partners

Crowe Horwath

Crystalline Mgmt.

Eaton Partners

EverWatch Capital

Food Group

Future Bright

Granite Creek Capital

Green America

H. I. G. Capital

Harvard Management

Headwaters MB

Hearst Corp.

Impact Agriculture Consulting 

International Finance Corp.

Kainos Capital

Key & Co.

Korn Ferry

Lakeshore Food Advisors

M. D. Sass Investors

Macquarie Bank Ltd.

Mercon Corp.

Paine Schwartz

Pipeline Foods

Prodos Capital Mgmt.


Riverside Mgmt.

Roundtable Investment Partners

Sugaright (Division of CSC Sugar )

Sustainable Insight Capital Management

TerraNova Capital

TIAA Investments

Tufts University

Tze Venture Search Fund

TZP Group


Wafra Investment Advisory Group


Blunt Talk About an Exciting
Burgeoning Industry




Private Equity Investing
In Cannabis Industry Companies



Troy Dayton

 Chief Executive Officer

The Arcview Group


Thursday, March 7, 2019

8:00 am – 5:00 pm

New York City





Duane Morris LLP
FTI Consulting Inc.



Tegan Adams, New Maple Holdings Ltd.

Elaine Carey, FTI Consulting Inc.

Benjamin Chiarelli, Cellibre LLC

Michael Correia, The National Cannabis Industry Association

Rafael De La Cruz, Universal Brand Ventures LLC

Carlos Dew, Superbad Inc.
David N. Feldman, Duane Morris LLP
Carolyn Gerin, Cannawise LLC

Lewis Goldberg, KCSA Strategic Communications

Steven Hawkins, Marijuana Policy Project

Robert Hunt, Linnaea Holdings

Mitchell Kahn, Grassroots Cannabis LLC
Kris Krane, 4 Front Holdings LLC

Harrison Phillips, Viridian Capital Advisors LLC

Tahira Rehmatullah, Hypur Ventures
Christiane Schuman Campbell, Duane Morris LLP
Michael Schwamm, Duane Morris LLP

Timothy Seymour, Seymour Asset Management

Brian Sheng, Arcview Group LLC
Jeanne Sullivan, Arcview Ventures

John M. Torrens, Vertical Companies

David Wenger, PurpleRock Cannabis Partners

Faculty | Schedule | Registration | Location | Sponsorship | Audio Package |

Last year, the legal cannabis market in North America reached $10 billion and now is predicted to more than double by 2022!


Forward-thinking private equity investors -- often backed by high-net worth individuals and family offices, and sovereign trusts -- have already made their entry into this rapidly evolving market, despite the fact that cannabis is legal for adult use in only ten U.S. states, and legal only for medical use in 32 states -- and currently remains illegal at the U.S. federal level.


Early PE movers in cannabis companies have invested in enterprises that showcase the wide range of opportunities, from companies that are “plant touching” to those that are ancillary to the growth or sale of cannabis, or located in Canada, where cannabis is now fully legal federally and already big business. The industry also is gaining traction in Europe and other foreign countries.


Here are a few examples of high-profile investors who have made a name for themselves in the sector so far --

  • Privateer Holdings, which is backed by Silicon Valley investor Peter Thiel.

  • MedMen, a publicly-traded company, has a venture capital arm that has partnered with Wicklow Capital.

  • Casa Verde Capital, a venture capital firm co-founded and backed by rapper Snoop Dogg.

Meanwhile, mainstream private equity firms are taking a closer look at investment possibilities in cannabis and readying for future moves. Already mainstream giant corporations are staking their claims -- e.g., Marlboro cigarette maker Altria is acquiring a 45% stake in Canadian cannabis producer Cronos Group. Once U.S. federal legalization opens the sector’s doors to institutional investors, it will be a game-changer for the whole industry.



You’ll gain valuable insight as our panelists assess the outlook for cannabis industry investment opportunities when you attend The Capital Roundtable’s all-day conference on Private Equity Investing in Cannabis Industry Companies on Thursday, March 7, 2019, in New York City.



Here Are Three Key Reasons Why You Should Join Us


  1. Find out how to navigate the fact that cannabis remains a U.S. federal crime.

  2. Understand the current status of Congressional efforts toward federal legalization.

  3. Discover large private equity firms’ plans to tackle the sector and where the most attractive investment opportunities lie.


For now, investors ready to enter the cannabis sector for the first time, and not put off by its high-risk profile, will find ample opportunities.


PE investors can pick among dozens of verticals within the cannabis industry beyond growing, processing or selling the product, including --

  • real estate
  • agtech
  • software
  • medical
  • social media

Experts say the end of prohibition is inevitable. Looking forward, PE firms will also increasingly need to deal with several major competitive challenges including --

  • the roles that the giant alcohol, tobacco, pharmaceutical, and beverage companies will play and are already playing in other markets

  • high purchase price multiples and public company valuations

  • the rapid consolidation in the space


Click here to hear our 21 speakers address such key points as -- 

  • What are tax and legal implications investors should consider when investing in the US?

  • Whether and how should investors interact with businesses that are “plant touching”?

  • What are medical and pharmaceutical opportunities related to cannabis businesses?

  • How can cannabis-related businesses access banking services?

  • Are big tobacco, alcohol, beverage and pharma companies competitors or allies to private equity investors?

  • How has legalization in Canada impacted valuations of cannabis-related companies?

  • What are some of the best exit routes for cannabis-related businesses?

  • What is the outlook for decriminalization at the federal level?

  • What will happen to portfolio companies’ business plans after legalization?


Register Now to Join Troy Dayton

And More Than 20 Other Experts


Troy Dayton is CEO of The Arcview Group, the first and largest group of investors dedicated to the cannabis sector. Since its founding in 2010, Arcview has helped 1400+ high net worth and institutional investors place more than $235 million behind 200+ cannabis related deals through their Arcview Investor Network. Arcview is also the top publisher of market research, data and analysis in the sector. In 2015, Arcview helped launch a partner business accelerator, CanopyBoulder, and in 2018 Arcview launched the Arcview Venture Fund. Forbes named Arcview among the top 5 financial firms in the sector and Business Insider named the group to their top 12 cannabis venture firms.


Dayton is also chairman of the board of the Marijuana Policy Project and was formerly its chief fundraiser. He is a founding and current board member of the National Cannabis Industry Association and co-founder of Students for Sensible Drug Policy, which is now on over 300 campuses.


Fortune Magazine, Details Magazine, and International Business Times all list Troy in their top 10 lists of the most influential people in the cannabis industry. 



 Recent Cannabis Industry Deals


  • Serruya Private Equity provided equity for Hydrofarm Holdings Group, a Petaluma, California-based independent wholesaler and manufacturer of hydroponic equipment and horticultural products.

  • In October, Green Acre Capital invested in The Friendly Stranger, a cannabis retailer, to fund its retail expansion plan.

  • MedMen Enterprises has sold a significant portion of its real estate assets to Treehouse Real Estate Investment Trust, a real estate investment vehicle.

  • Merida Capital Partners is the biggest outside investor in Kush Bottles, which focuses on wholesale cannabis packaging.

  • Private equity firm Tuatara Capital has invested in singer Willie Nelson’s cannabis brand Willie’s Reserve.

  • Tuatara also backed TeeWinot Life Sciences, a biopharmaceutical company specializing in the production of cannabinoids.

  • iAnthus Capital, a Multistate marijuana firm has agreed to acquire the U.S. assets of Toronto-based cannabis company MPX Bioceutical Corp.

  • Vancouver based Cannex Capital Holdings and 4Front Holdings, an Arizona-based multistate marijuana firm, have announced plans to merge.

This Capital Roundtable conference is the ideal place to expand your network and open up pathways to future deals. The day’s agenda includes ample time to let you --

  • Meet fellow attendees and featured speakers
  • Enhance your personal database with valuable new connections
  • Share both ideas and business cards
  • Meet potential investment partners and clients

Keep in mind this conference is certain to fill up quickly, so you’ll want to register as soon as possible to assure yourself a seat. To avoid disappointment, please contact Chris Agar today to confirm your attendance at 212-832-7300 ext. 0 or


 Who Should Attend


Designed to Meet the Needs of GPs, LPs, & Managers of Buyout, Growth Equity, Mezzanine, BDC, and Lending Funds, as Well as Independent Sponsors, Operating Partners, Portfolio Company Managers, and the Bankers, Lawyers, Accountants, & Other Advisors Who Support Them.




We look forward to having you join us on Thursday, March 7, 2019.


Conference Organizers


This conference is being produced by The Capital Roundtable, America’s leading conference organization focusing on “need-to-know” information for professionals in the middle-market private equity community.  For more information about The Capital Roundtable’s 30 annual conferences and other events and programs, please visit




 Speaking & Business Development Opportunities


We offer excellent speaking, marketing, and business development opportunities to reach the middle‑market private equity community. For more details, please contact Kellie Green or Claire Notton at 212-832-7300 or by email at or




Have a Question?


Please contact Sacha Spitzer at or 212-832-7300 ext. 0.




Who We Are


This Capital Roundtable conference in midtown, New York City, is all-business, all-targeted, all-designed to be a completely focused day of practical information and revealing insights. You’ll gain valuable insights from --

  • Three informative panel discussions
  • Two revealing keynote presentations
  • Real-world perspectives from PE investors
  • Industry outlooks from noted experts
  • War stories and lessons learned from experienced hands

^ Back to Top ^


Chaired By

  • Troy Dayton, Chief Executive Oficer, The Arcview Group


Hosted By

  • Burt Alimansky, Chairman & CEO, The Capital Roundtable



  • Tegan Adams, Chief Executive Officer, New Maple Holdings Ltd.
  • Elaine Carey, Managing Director, FTI Consulting Inc.
  • Benjamin Chiarelli, Founder & CEO, Cellibre LLC
  • Michael Correia, Dir.--Government Relations, The National Cannabis Industry Association
  • Rafael De La Cruz, Managing Partner, Universal Brand Ventures LLC
  • Carlos Dew, Founder & Chairman, Superbad Inc.
  • David N. Feldman, Partner, Duane Morris LLP
  • Carolyn Gerin, Chief Executive Officer, Cannwise LLC
  • Lewis Goldberg, Managing Partner, KCSA Strategic Communications
  • Steven Hawkins, Executive Director, Marijuana Policy Project
  • Robert Hunt, Principal, Linnaea Holdings
  • Mitchell Kahn, Chief Executive Officer, Grassroots Cannabis LLC
  • Kris Krane, Co-Founder & President, 4 Front Holdings LLC
  • Harrison Phillips, Vice President, Viridian Capital Advisors LLC
  • Tahira Rehmatullah, Managing Director, Hypur Ventures
  • Christiane Schuman Campbell, Partner, Duane Morris LLP
  • Michael Schwamm, Partner, Duane Morris LLP
  • Timothy Seymour, Chief Information Officer, Seymour Asset Management
  • Brian Sheng, General Partner, Arcview Group LLC
  • Jeanne Sullivan, General Partner, Arcview Ventures
  • John M. Torrens, President, Vertical Companies
  • David Wenger, Partner, PurpleRock Cannabis Partners

^ Back to Top ^




  • 07:30-08:30

    Networking & Registration & Breakfast


    Welcoming Remarks & Audience Self-Introductions


    Conference Chairman’s Introduction --

    • Troy Dayton, The Arcview Group
    09:30-10:00 Morning Keynote -- David N. Feldman, Duane Morris LLP


    Networking & Coffee


    10:45-11.45 First Panel --

    The Changing Face of the Law –
    What New Opportunities Will the End of Prohibition Bring?


    Morning Conversation --

    Medical Cannabis & CBD --  

    Where Are the Best Opportunities in Pharmaceuticals, Nutraceuticals, & Genomics


    Networking & Luncheon



    Second Panel -- 
    Bringing Pot Mainstream –

    How to Uniquely Position, Build, & Protect Your Brand


    Networking & Dessert



    Afternoon Conversation --

    Joining the Green Rush --  

    Innovative Strategies for Deal Making



    Third Panel --

    Four Experts Argue Pros & Cons

    Of Cannabis Business Opportunities



    Networking & Adjournment



^ Back to Top ^


Space at this conference is limited, so register as soon as possible to assure yourself a seat. To avoid disappointment, please contact Chris Agar today to confirm your attendance at 212-832-7300 ext. 0 or


Please note that The Capital Roundtable limits the number of registrants from a single firm to three.


  • Best Rate -- Early Registration -- Save $400 off the standard fee of $1495 when you register by Friday, January 11. Just $1095.


  • Incentive Registration -- save $200 off the standard fee!
    Register by Friday, February 1, and the fee for the conference is $1295.


  • Conference Rate -- $1,495 increasing to $1,595 day of conference, space permitting.


  • Group Rate -- $995 each, when you register two or more people to attend from the same company.


Register Now


You can pay by credit card (using the links above) or by check. Mail your check and business card to: New York Business Roundtable Inc., 747 Third Avenue, Suite 200, New York, NY 10017.

Have a special question? Please contact Chris Agar at or 212-832-7300 ext. 0.


From time to time, for reasons beyond Capital Roundtable's control, program schedules and speakers become subject to change.  We make every effort to announce substantive changes by email to registrants at least 48 hours in advance.

^ Back to Top ^


Midtown, NYC

^ Back to Top ^

Audio Package

Can't attend but want to hear the program? You can buy the audio package along with the handouts. Purchase the audio package online now.

^ Back to Top ^


We offer excellent marketing and business development opportunities to reach the middle‑market private equity community. For more details, please contact Claire Notton at 212-832-7300 ext.117, or by email at


^ Back to Top ^